Knollwood Investment Advisory, LLC Neurocrine Biosciences Inc Transaction History
Knollwood Investment Advisory, LLC
- $905 Billion
- Q1 2025
A detailed history of Knollwood Investment Advisory, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Knollwood Investment Advisory, LLC holds 6,607 shares of NBIX stock, worth $837,172. This represents 0.08% of its overall portfolio holdings.
Number of Shares
6,607
Previous 6,607
-0.0%
Holding current value
$837,172
Previous $902 Million
18.97%
% of portfolio
0.08%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.6MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.8 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.26 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$701 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$616 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$338 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...